{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:05:24Z","timestamp":1787313924273,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["U01DK108809"],"award-info":[{"award-number":["U01DK108809"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["HL159081"],"award-info":[{"award-number":["HL159081"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["HL161303"],"award-info":[{"award-number":["HL161303"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Machine learning and large-scale proteomics led to a 16-protein secondary cardiovascular risk model in patients with CKD.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Hepatic fibrosis and liver X receptor activation represented biologic pathways that link kidney disease and risk of secondary cardiovascular events.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>An understanding of the circulating proteins associated with secondary cardiovascular events may help to identify novel therapeutic targets.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular risk models have been developed primarily for incident events. Well-performing models are lacking to predict secondary cardiovascular events among people with a history of coronary heart disease, stroke, or heart failure who also have CKD. We sought to develop a proteomic risk score for cardiovascular events in individuals with CKD and a history of cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We measured 4638 plasma proteins among 1067 participants from the Chronic Renal Insufficiency Cohort (CRIC) and 536 individuals from the Atherosclerosis Risk in Communities (ARIC) Cohort. All had non\u2013dialysis-dependent CKD and coronary heart disease, heart failure, or stroke at study baseline. A proteomic risk model for secondary cardiovascular events was derived by elastic net regression in CRIC, validated in ARIC, and compared with clinical models. Biologic mechanisms of secondary events were characterized through proteomic pathway analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A 16-protein risk model was superior to the Framingham Risk Score for secondary events, including a modified score that included eGFR. In CRIC, the annualized area under the receiver operating characteristic curve (area under the curve) within 1\u20135 years ranged between 0.77 and 0.80 for the protein model and 0.57 and 0.72 for the clinical models. These findings were replicated in the ARIC validation cohort. Biologic pathway analysis identified pathways and proteins for cardiac remodeling and fibrosis, vascular disease, and thrombosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The proteomic risk model for secondary cardiovascular events outperformed clinical models on the basis of traditional risk factors and eGFR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.0000000502","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T12:08:23Z","timestamp":1727352503000},"page":"231-241","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Proteomic Assessment of the Risk of Secondary Cardiovascular Events among Individuals with CKD"],"prefix":"10.1681","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8250-2607","authenticated-orcid":false,"given":"Rajat","family":"Deo","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0498-1980","authenticated-orcid":false,"given":"Ruth F.","family":"Dubin","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-8633","authenticated-orcid":false,"given":"Yue","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4572-2608","authenticated-orcid":false,"given":"Harold","family":"Feldman","sequence":"additional","affiliation":[{"name":"Patient-Centered Outcomes Research Institute, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-047X","authenticated-orcid":false,"given":"Haochang","family":"Shou","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4598-0669","authenticated-orcid":false,"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland"},{"name":"Department of Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-6023","authenticated-orcid":false,"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[{"name":"Division of Precision Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4978-5980","authenticated-orcid":false,"given":"Aditya L.","family":"Surapaneni","sequence":"additional","affiliation":[{"name":"Division of Precision Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-079X","authenticated-orcid":false,"given":"Jordana B.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"},{"name":"Renal, Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2552-8744","authenticated-orcid":false,"given":"Mayank","family":"Kansal","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Illinois at Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9025-7413","authenticated-orcid":false,"given":"Mahboob","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9059-9998","authenticated-orcid":false,"given":"Mirela","family":"Dobre","sequence":"additional","affiliation":[{"name":"Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8286-9652","authenticated-orcid":false,"given":"Jiang","family":"He","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7348-4451","authenticated-orcid":false,"given":"Tanika","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9109-0811","authenticated-orcid":false,"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California"},{"name":"The Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Kimmel","sequence":"additional","affiliation":[{"name":"Division of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7357-5970","authenticated-orcid":false,"given":"Ramachandran S.","family":"Vasan","sequence":"additional","affiliation":[{"name":"Section of Preventive Medicine and Epidemiology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts"},{"name":"Section of Cardiology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts"},{"name":"Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4213-3138","authenticated-orcid":false,"given":"Mark R.","family":"Segal","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3662-3907","authenticated-orcid":false,"given":"Hongzhe","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0437-8882","authenticated-orcid":false,"given":"Peter","family":"Ganz","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Zuckerberg San Francisco General Hospital and Department of Medicine, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"issue":"13","key":"B1-20250203","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med."},{"issue":"6","key":"B2-20250203","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int."},{"issue":"15","key":"B3-20250203","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med."},{"issue":"24","key":"B4-20250203","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med."},{"issue":"2","key":"B5-20250203","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med."},{"issue":"23","key":"B6-20250203","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med."},{"issue":"10","key":"B7-20250203","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B8-20250203","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med."},{"issue":"25 suppl 2","key":"B9-20250203","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American heart association Task Force on practice guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation."},{"issue":"15","key":"B10-20250203","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2015.08.035","article-title":"10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic study of atherosclerosis) with validation in the HNR (Heinz Nixdorf recall) study and the DHS (Dallas heart study)","volume":"66","author":"McClelland","year":"2015","journal-title":"J Am Coll Cardiol."},{"issue":"2 Pt 1","key":"B11-20250203","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0002-8703(00)90236-9","article-title":"Primary and subsequent coronary risk appraisal: new results from the Framingham study","volume":"139","author":"D'Agostino","year":"2000","journal-title":"Am Heart J."},{"issue":"15","key":"B12-20250203","doi-asserted-by":"crossref","first-page":"e016463","DOI":"10.1161\/JAHA.120.016463","article-title":"Impact of kidney function on the blood proteome and on protein cardiovascular risk biomarkers in patients with stable coronary heart disease","volume":"9","author":"Yang","year":"2020","journal-title":"J Am Heart Assoc."},{"issue":"23","key":"B13-20250203","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/eurheartj\/ehad115","article-title":"Proteomic cardiovascular risk assessment in chronic kidney disease","volume":"44","author":"Deo","year":"2023","journal-title":"Eur Heart J."},{"issue":"8","key":"B14-20250203","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"B15-20250203","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. The ARIC investigators","volume":"129","year":"1989","journal-title":"Am J Epidemiol."},{"issue":"12","key":"B16-20250203","doi-asserted-by":"crossref","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One."},{"issue":"3","key":"B17-20250203","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jalm\/jfac145","article-title":"Analytical and biological variability of a commercial modified aptamer assay in plasma samples of patients with chronic kidney disease","volume":"8","author":"Dubin","year":"2023","journal-title":"J Appl Lab Med."},{"issue":"2","key":"B18-20250203","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1681\/ASN.2014101045","article-title":"Electrocardiographic measures and prediction of cardiovascular and noncardiovascular death in CKD","volume":"27","author":"Deo","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"13","key":"B19-20250203","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJM199809243391301","article-title":"Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994","volume":"339","author":"Rosamond","year":"1998","journal-title":"N Engl J Med."},{"issue":"4","key":"B20-20250203","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.STR.30.4.736","article-title":"Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort","volume":"30","author":"Rosamond","year":"1999","journal-title":"Stroke."},{"issue":"4","key":"B21-20250203","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCHEARTFAILURE.111.964841","article-title":"Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"5","author":"Agarwal","year":"2012","journal-title":"Circ Heart Fail."},{"issue":"1","key":"B22-20250203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw."},{"issue":"5","key":"B23-20250203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for cox's proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J Stat Softw."},{"issue":"1","key":"B24-20250203","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.csda.2006.12.019","article-title":"Relaxed lasso","volume":"52","author":"Meinshausen","year":"2007","journal-title":"Comput Stat Data Anal."},{"issue":"2","key":"B25-20250203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics."},{"issue":"4","key":"B26-20250203","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1073\/pnas.1814092116","article-title":"The harmonic mean p-value for combining dependent tests","volume":"116","author":"Wilson","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"10","key":"B27-20250203","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/sim.6428","article-title":"Tests of calibration and goodness-of-fit in the survival setting","volume":"34","author":"Demler","year":"2015","journal-title":"Stat Med."},{"issue":"10","key":"B28-20250203","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/CIRCULATIONAHA.117.028213","article-title":"Improving assessment of drug safety through proteomics: early detection and mechanistic characterization of the unforeseen harmful effects of torcetrapib","volume":"137","author":"Williams","year":"2018","journal-title":"Circulation."},{"issue":"9","key":"B29-20250203","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.2337\/dc20-0456","article-title":"Mechanisms of sodium-glucose cotransporter 2 inhibition: insights from large-scale proteomics","volume":"43","author":"Ferrannini","year":"2020","journal-title":"Diabetes Care."},{"issue":"5","key":"B30-20250203","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.ajkd.2003.12.048","article-title":"Clinical significance of cardiac troponin T levels in chronic kidney disease patients: predictive value for cardiovascular risk","volume":"43","author":"Goicoechea","year":"2004","journal-title":"Am J Kidney Dis."},{"issue":"12","key":"B31-20250203","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ki.2012.301","article-title":"Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients","volume":"82","author":"Liabeuf","year":"2012","journal-title":"Kidney Int."},{"issue":"3","key":"B32-20250203","doi-asserted-by":"crossref","first-page":"e22056","DOI":"10.1002\/jcla.22056","article-title":"Associations among serum beta 2 microglobulin, malnutrition, inflammation, and advanced cardiovascular event in patients with chronic kidney disease","volume":"31","author":"Wu","year":"2017","journal-title":"J Clin Lab Anal."},{"issue":"2","key":"B33-20250203","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000335579","article-title":"Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease","volume":"35","author":"Gardiner","year":"2012","journal-title":"Am J Nephrol."},{"key":"B34-20250203","doi-asserted-by":"crossref","first-page":"854070","DOI":"10.1155\/2015\/854070","article-title":"Kidney injury molecule-1 and cardiovascular diseases: from basic science to clinical practice","volume":"2015","author":"Medic","year":"2015","journal-title":"Biomed Res Int."},{"issue":"21","key":"B35-20250203","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/eurheartj\/ehr190","article-title":"Clinical outcome of renal tubular damage in chronic heart failure","volume":"32","author":"Damman","year":"2011","journal-title":"Eur Heart J."},{"issue":"2","key":"B36-20250203","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11255-010-9897-2","article-title":"Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease","volume":"44","author":"Lishmanov","year":"2012","journal-title":"Int Urol Nephrol."},{"issue":"2","key":"B37-20250203","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int."},{"issue":"11","key":"B38-20250203","doi-asserted-by":"crossref","first-page":"100725","DOI":"10.1016\/j.xkme.2023.100725","article-title":"Copeptin, natriuretic peptides, and cardiovascular outcomes in patients with CKD: the German chronic kidney disease (GCKD) study","volume":"5","author":"Schneider","year":"2023","journal-title":"Kidney Med."},{"issue":"8","key":"B39-20250203","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/jama.2011.163","article-title":"Index event bias as an explanation for the paradoxes of recurrence risk research","volume":"305","author":"Dahabreh","year":"2011","journal-title":"JAMA."},{"issue":"1","key":"B40-20250203","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00395-012-0323-z","article-title":"Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia-reperfusion injury","volume":"108","author":"Lei","year":"2013","journal-title":"Basic Res Cardiol."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:45:15Z","timestamp":1786131915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000000502","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]},"assertion":[{"value":"2024-04-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}